Rothstein K D, Munoz S J
Center for Liver Diseases, Albert Einstein Medical Center, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
Clin Lab Med. 1996 Jun;16(2):465-91.
Interferon is currently the only approved medication in the United States for treatment of chronic hepatitis B and C infections. The mechanism of action of interferon and guidelines for its administration are reviewed. Important clinical studies involving its use in hepatitis B and C infections are discussed, and investigational therapies for chronic viral hepatitis are highlighted.
干扰素是目前美国唯一获批用于治疗慢性乙型和丙型肝炎感染的药物。本文综述了干扰素的作用机制及其给药指南。讨论了涉及干扰素在乙型和丙型肝炎感染中应用的重要临床研究,并着重介绍了慢性病毒性肝炎的研究性治疗方法。